Healthy Inc > Blog > Sitagliptin manufacturer India
Posted on:

What is the best time to take sitagliptin 100 mg?

In the pharmaceutical industry, Sitagliptin is a highly selective, orally active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. As a pharmacist and manufacturer, I view this molecule as an “Incretin Enhancer”—it is technically superior to older anti-diabetics because it only stimulates insulin release when blood sugar is high, significantly reducing the risk of hypoglycemia.

At your WHO-GMP facility in Mumbai, Sitagliptin 100 mg is a premium “Gliptin” SKU. For your digital platforms, highlighting its “Glucose-Dependent” mechanism is a major technical differentiator for clinician and B2B buyer interest.

Therapeutic Profile: Optimal Timing

The best time to take Sitagliptin 100 mg is once daily, at the same time every morning.

Timing Protocol Recommendation Technical Rationale
Morning Dosing Preferred Provides maximum DPP-4 inhibition during the day when carbohydrate intake (meals) is highest.
With or Without Food Either Its bioavailability is not affected by food; it can be taken on an empty stomach or with breakfast.
Consistency Critical It has a terminal half-life of approximately 12 hours, requiring a 24-hour cycle to maintain steady-state plasma levels.
Missed Dose Immediate If a dose is missed, it should be taken as soon as remembered, but never double the dose to catch up.

Mechanism: DPP-4 Inhibition & Incretin Preservation

[Image showing Sitagliptin blocking the DPP-4 enzyme to allow GLP-1 and GIP to stimulate insulin release from the pancreas]

Sitagliptin works by protecting the body’s natural blood-sugar regulators:

Incretin Release: After eating, the gut releases “incretin” hormones (GLP-1 and GIP).

The DPP-4 Threat: Normally, the DPP-4 enzyme destroys these hormones within minutes.

Enzyme Blockade: Sitagliptin competitively inhibits DPP-4, extending the life of GLP-1 and GIP.

Dual Action: This causes the pancreas to produce more insulin and the liver to produce less glucose, but only when blood sugar is elevated.

The Pharmacist’s “Technical Warning”

  • The “Renal” Threshold: As a pharmacist, I must emphasize that Sitagliptin is primarily cleared by the kidneys ($79\%$). If a patient’s Creatinine Clearance (CrCl) drops below $45\text{ mL/min}$, the 100 mg dose must be reduced to 50 mg or 25 mg to avoid toxicity.

  • Pancreatitis Alert: Patients should be warned to stop the medication immediately if they experience persistent, severe abdominal pain (radiating to the back), as Acute Pancreatitis is a rare but serious technical risk.

  • Joint Pain (Arthralgia): DPP-4 inhibitors have been linked to severe, disabling joint pain. If this occurs, the medication should be discontinued.

  • Bullous Pemphigoid: A rare autoimmune skin reaction (blistering) has been reported; patients should report any unusual skin changes immediately.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Weight Neutral” USP: On your digital marketplace, position Sitagliptin as a “Weight-Neutral” therapy. Unlike sulfonylureas or insulin, it does not cause weight gain, making it highly attractive for modern Type 2 Diabetes management.

  • Stability for Export: Sitagliptin phosphate is highly stable but moisture-sensitive. Utilizing Alu-Alu blister packaging is the global benchmark for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for all strengths (25/50/100 mg) to support your firm’s registration in international tenders for metabolic health.

Sitagliptin Tablet

Posted on:

What is Sitagliptin 100mg used for?

In the pharmaceutical industry, Sitagliptin 100 mg is a highly selective, orally active Dipeptidyl Peptidase-4 (DPP-4) inhibitor, often referred to as a “Gliptin.”

As a pharmacist and manufacturer, I view the 100 mg strength as the standard therapeutic daily dose for most adults. Its primary value in your export portfolio is its “weight-neutral” profile and its low risk of causing hypoglycemia compared to older drugs like Sulfonylureas.

Primary Clinical Uses

  • Type 2 Diabetes Mellitus: Indicated as an adjunct to diet and exercise to improve glycemic control.

  • Monotherapy: Used when Metformin is not tolerated or is contraindicated.

  • Combination Therapy: Most commonly prescribed alongside Metformin, Pioglitazone, or Insulin to achieve HbA1c targets.

  • Cardiovascular Safety: It is often preferred for diabetic patients with heart concerns, as it does not increase the risk of heart failure (unlike some other Gliptins).

  • Mechanism of Action: The Incretin Enhancer

Sitagliptin works by harnessing the body’s natural response to food.

Incretin Hormone Protection: When we eat, the gut releases hormones called Incretins (like GLP-1). These hormones tell the pancreas to release insulin.

Enzyme Inhibition: Normally, an enzyme called DPP-4 breaks down these Incretin hormones very quickly.

Extended Action: Sitagliptin blocks (inhibits) the DPP-4 enzyme. This allows the Incretin hormones to stay active in the blood for much longer.

Glucose-Dependent Insulin: By keeping Incretins active, Sitagliptin triggers the pancreas to produce more insulin and the liver to produce less glucose—but only when blood sugar is high. This “glucose-dependent” mechanism is why it rarely causes a dangerous drop in blood sugar.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Sitagliptin 100 mg is a high-value “blockbuster” generic:

  • The 100 mg Standard: Since this is the most common dose, your manufacturing line should be optimized for high-volume film-coated tablets.

  • BCS Class I Characteristics: Sitagliptin Phosphate Monohydrate is highly soluble and permeable. At our facility, we focus on maintaining a strict dissolution profile (Q > 80% in 30 minutes) to ensure your generic version is bioequivalent to the innovator (Januvia).

  • Stability in Tropical Climates: Sitagliptin is stable, but we utilize Alu-Alu blister packaging to ensure a 36-month shelf life. This is a significant USP for your digital platform when targeting buyers in Zone IVb regions (Africa/SE Asia).

  • Renal Dosing Note: As a pharmacist, you know that patients with moderate to severe kidney issues require lower doses (25 mg or 50 mg). Highlighting this technical knowledge in your Product Information Leaflets (PIL) builds immense trust with international B2B medical directors.

Sitagliptin Tablet

Add to cart